Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China · Delayed Price · Currency is CNY 48.82
+2.38 (5.12%)
At close: Sep 14, 2026
SHE:301281 Revenue
Shandong Keyuan Pharmaceutical had revenue of 170.16M CNY in the quarter ending June 30, 2026, with 45.86% growth. This brings the company's revenue in the last twelve months to 501.83M, up 10.43% year-over-year. In the year 2025, Shandong Keyuan Pharmaceutical had annual revenue of 398.23M, down -14.12%.
Revenue (ttm)
501.83M
Revenue Growth
+10.43%
P/S Ratio
10.02
Revenue / Employee
772.04K
Employees
650
Market Cap
5.03B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 398.23M | -65.49M | -14.12% |
| Dec 31, 2024 | 463.72M | 16.13M | 3.60% |
| Dec 31, 2023 | 447.58M | 4.72M | 1.07% |
| Jan 1, 2023 | 442.87M | 21.98M | 5.22% |
| Jan 1, 2022 | 420.89M | 53.83M | 14.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.